- What is lopinavir and ritonavir, and how does it work (mechanism of action)?
- Can lopinavir and ritonavir treat the COVID-19 coronavirus?
- What are the side effects of lopinavir and ritonavir?
- What is the dosage for lopinavir and ritonavir?
- Which drugs or supplements interact with lopinavir and ritonavir?
- Is lopinavir and ritonavir safe to take if you are pregnant or breastfeeding?
- What else should you know about lopinavir and ritonavir?
What is lopinavir and ritonavir, and how does it work (mechanism of action)?
Kaletra is an oral medication that is a combination of lopinavir and ritonavir. It is used for treating infections with the human immunodeficiency virus (HIV). It is in a class of drugs called protease inhibitors which, among others, includes ritonavir (Norvir), nelfinavir (Viracept) and saquinavir (Invirase, Fortovase). Although both lopinavir and ritonavir inhibit the HIV virus, they are combined in Kaletra because ritonavir increases the concentration of lopinavir in the body. In fact, the activity of Kaletra against HIV is due to the lopinavir because the amount of ritonavir in Kaletra is not enough to inhibit the HIV virus.
During infection with HIV, the HIV virus multiplies within the body's cells. Viruses are released from the cells and spread throughout the body where they infect other cells. In this manner, HIV infection is perpetuated among new cells that the body produces continually. During the production of the viruses, new proteins for the viruses are made. Some of the proteins are structural proteins, that, is, proteins that form the body of the virus. Other proteins are enzymes which manufacture DNA and other components for the new viruses. Protease is the enzyme that forms the new structural proteins and enzymes. The lopinavir in Kaletra blocks the action of protease and results in the formation of defective viruses that are unable to infect the body's cells. As a result, the number of viruses in the body (the viral load) decreases. Nevertheless, Kaletra does not prevent the transmission of HIV among individuals, and it does not cure HIV infections or AIDS.
Can lopinavir and ritonavir treat the COVID-19 coronavirus?
Most viruses have the ability to create proteins necessary for their life cycle. The lopinavir and ritonavir combination stops that process, in theory. For viruses to create their DNA or RNA (RNA in the case of SARS-nCov-2) the virus has to take control of some of the proteins in the host cell.
The virus relies on an enzyme called protease. Imagine the virus replication process as feeding dough into a pasta maker. The protease acts as a pair of scissors at the end, snipping off lengths of pasta as they come out of the machine to make the amino acids necessary for the virus to replicate itself.
What lopinavir and ritonavir aim to do as protease inhibitors is jam up that pair of scissors.
A lot of the experience with lopinavir and ritonavir, as with all the drugs the medical community is trying against the coronavirus pandemic, is drawn from the experience with the SARS outbreak in 2003. It was an option, but not clearly effective against the virus, according to trials done at the time.
Unfortunately, nothing tried in the SARS and later MERS epidemics was obviously effective, but there were signals that some of these drugs might be useful.
As of this article’s publication date of April 7, 2020, the most recent study on lopinavir and ritonavir was published March 2020 in the New England Journal of Medicine where they compared lopinavir and ritonavir with the current standard of care (supportive care to alleviate symptoms with no antiviral medication).
The conclusion was there was no increased benefit compared with the standard supportive care, but that study is not the last word on lopinavir and ritonavir's effectiveness against the SARS-nCoV-2 virus. Further studies are underway, including the World Health Organization's Solidarity study. This study allows healthcare providers around the world to provide observational data on a list of promising drugs now in use to help determine whether they really provide benefit or not.
The lopinavir and ritonavir combination is on that list, so doctors will know more as data comes in.
COVID-19 section data provided by Dominic Chan, a Pharm. D. and infectious disease specialist at Legacy Health System in Oregon.
What are the side effects of lopinavir and ritonavir?
The most common side effects of Kaletra are:
Kaletra may cause liver failure and failure of the pancreas. Like other protease inhibitors use of Kaletra may be associated with:
- redistribution or accumulation of body fat,
- increased cholesterol,
- worsening of diabetes, and
- abnormal heart rhythms.
Kaletra should be used cautiously in patients with pre-existing heart conditions.
What is the dosage for lopinavir and ritonavir?
Kaletra tablets may be administered with or without food. Oral solution and capsules should be administered with food. There are several dosing regimens depending on the formulation used, age of the patient, previous exposure to lopinavir, or use of other drugs. Here are some examples.
- Therapy-naive adult patients: 400/100 tablets (3 capsules) twice daily or 800/200 (6 capsules) once daily; Oral solution, 5 mL twice daily or 10 mL once daily with food.
- Therapy-experienced adult patients: 200/50 tablets, two twice daily or 3 capsules twice daily; Oral solution 5 mL twice daily. Once daily administration of Kaletra is not recommended.
- Children between 6 months and 18 years of age: The recommended dose is 230/57.5/m2 of the oral solution given twice daily and not to exceed the recommended adult dose. Kaletra should not be administered once daily in patients less than 18 years of age.
- Children between 14 days and 6 months of age: The recommended dose is 16/4/kg or 300/75/m2 of the oral solution given twice daily.
- In combination with efavirenz (Sustiva), nevirapine (Viramune), fosamprenavir (Lexiva) or nelfinavir (Viracept): Once daily administration is not recommended when combined with efavirenz, nevirapine, fosamprenavir or nelfinavir. For adults, the recommended dose is two 200/50 tablets and one 100/25 tablet twice daily; Oral solution, 6.5 mL twice daily. For children, the recommended dose is 300/75/m2 not to exceed the adult dose.
Latest HIV News
Daily Health News
Which drugs or supplements interact with lopinavir and ritonavir?
Kaletra interacts with many drugs. Some of the important interactions are mentioned below. Patients should consult their healthcare provider before combining any drug with Kaletra.
Kaletra should not be used together with amiodarone (Cordarone), quinidine (Quinaglute, Cardioquin), triazolam (Halcion), midazolam (Versed), pimozide (Orap), ergotamine derivatives (for example, Ergostat), propafenone (Rythmol) and flecainide (Tambocor) because Kaletra increases the levels of these drugs in the body and as a result may lead to serious adverse effects of these drugs.
Kaletra may also prevent the break down of lovastatin (Mevacor), simvastatin (Zocor), rosuvastatin (Crestor) and atorvastatin (Lipitor), causing their levels in the body to rise. This may increase the occurrence of muscle breakdown (rhabdomyolysis), which is a side effect of these drugs. Therefore, lovastatin and simvastatin should not be combined with Kaletra; the dose of rosuvastatin should not exceed 10 mg/day and the lowest dose of atorvastatin should be used. The blood concentration of rifabutin (Mycobutin) and sildenafil (Viagra) can be increased by Kaletra. Therefore, the doses of rifabutin and sildenafil should be reduced.
Kaletra can reduce the effectiveness of oral contraceptives.
Rifampin (Rifadin), St. John's wort, efavirenz (Sustiva) and nevirapine (Viramune) decrease the blood levels of Kaletra and this can reduce the effectiveness of Kaletra.
Is lopinavir and ritonavir safe to take if you are pregnant or breastfeeding?
What else should you know about lopinavir and ritonavir?
What preparations of lopinavir and ritonavir are available?
Tablets (mg lopinavir/mg ritonavir): 100/25 and 200/50. Oral solution: 80/20 per mL. Capsules: 133/33.3.
How should I keep lopinavir and ritonavir stored?
Capsules and solution should be refrigerated at 2 C to 8 C (36 F to 46 F). If stored at room temperature, the capsules and solution should be used within 2 months. Tablets should be stored at 15 C to 30 C (59 F to 86 F).
Subscribe to MedicineNet's General Health Newsletter
Lopinavir and ritonavir (Kaletra) is a combination drug for human immunodeficiency virus (HIV). The combination is also under investigation as potentially effective against the SARS-nCoV-2 virus that causes the COVID-19 coronavirus disease. There is yet no solid data it works, but studies are ongoing as of April 2020.
Multimedia: Slideshows, Images & Quizzes
Novel Coronavirus (COVID-19) Prevention: Frequently Asked Questions
Why is coronavirus considered dangerous? What are symptoms you should look for? Take this quiz to learn how to protect yourself.
Coronavirus COVID-19 Prevention: Test Your Medical IQ
What's really the best way to prevent the spread of new coronavirus COVID-19? Should wear a mask or not? Take this quiz to find...
Picture of HIV/AIDS
Acronym for the Human Immunodeficiency Virus, the cause of AIDS (acquired immunodeficiency syndrome). See a picture of HIV/AIDS...
Coronavirus COVID-19 (SARS-CoV-2) Pandemic Outbreak: What You Need to Know
A new strain of coronavirus (COVID-19, SARS-CoV-2) was reported from Wuhan, China in December, 2019. This outbreak of respiratory...
Coronavirus COVID-19 (SARS-CoV-2): The Latest News, Updates and Information
See the latest news updates and information on the Coronavirus COVID-19 outbreak. Learn about symptoms, prevention, possible...
What Drugs May Fight COVID-19? Drug Trials, Treatments, Vaccines
What drugs could help fight coronavirus COVID-19? Clinical studies are ongoing for antiviral drugs like hydroxychloroquine,...
Related Disease Conditions
Human Immunodeficiency Virus (HIV)
HIV (human immunodeficiency virus) infection left untreated causes AIDS (acquired immunodeficiency syndrome). Still incurable, AIDS describes immune system collapse that opens the way for opportunistic infections and cancers to kill the patient. Early symptoms and signs of HIV infection include flu-like symptoms and fungal infections, but some people may not show any symptoms for years. Highly active antiretroviral therapy (ART) is the standard treatment for HIV infection. These combination drug regimens have made HIV much less deadly, but a cure or vaccine for the pandemic remains out of reach. HIV is usually transmitted through sexual contact or sharing IV drug needles, but can also infect someone through contact with infected blood. Sexual abstinence, safe sex practices, quitting IV drugs (or at least using clean needles), and proper safety equipment by clinicians and first responders can drastically reduce transmission rates for HIV/AIDS.
AIDS (Acquired Immunodeficiency Syndrome)
AIDS is the advanced stage of HIV infection. Symptoms and signs of AIDS include pneumonia due to Pneumocystis jiroveci, tuberculosis, toxoplasmosis, seizures, weakness, meningitis, yeast infection of the esophagus, and Kaposi's sarcoma. Anti-retroviral therapy (HAART) is used in the treatment of AIDS.
COVID-19 (Coronavirus, 2019-nCoV)
Infection with COVID-19 (2019 novel coronavirus, 2019-nCoV) causes respiratory problems in humans. Transmission of COVID-19 occurs mainly through contact with respiratory sections from an infected person, however, fecal contamination may also spread the virus. Symptoms start off flu-like and progress to coughing, fever, shortness of breath, shaking chills, headache, loss of sense of taste and/or smell, muscle pain, and sore throat. Treatment focuses on supportive care and symptom relief.
COVID-19 (Coronavirus) Prevention Tips
COVID-19 is a novel coronavirus that spreads from person to person via infected respiratory droplets. The main symptoms of COVID-19 infection include cough, fever, and shortness of breath. Occasionally, people infected with COVID-19 may experience diarrhea, a sore throat, a runny or stuffy nose, or aches and pains. Avoiding contact with infected people, social distancing, not touching your face, frequent hand washing, cleaning, and disinfecting of frequently touched surfaces can help to reduce your risk of contracting the 2019 novel coronavirus.
COVID-19 vs. Flu vs. Cold
When you're feeling sick, it can be difficult to distinguish the symptoms of a COVID-19 infection from the symptoms of the common cold or the flu (influenza). While fever is common with the flu and COVID-19, sneezing is typically only associated with colds. Though sore throats are typical with colds, they are uncommon with COVID-19 infections and the flu.
Treatment & Diagnosis
- Wuhan Coronavirus FAQs
- Coronavirus COVID-19 Prevention FAQs
- What Are Monoclonal Antibody Treatments for COVID-19 Coronavirus?
- Testing Is Key to COVID-19 Recovery for Patients and Economy
- Should I Go to the Dentist During the COVID-19 Pandemic?
- Is the Test for COVID-19 Coronavirus Reliable?
- What if I get COVID-19 with Rheumatoid Arthritis?
- How Long Can the COVID-19 Coronavirus Survive?
- What if I get COVID-19 with Diabetes?
- What if I Get COVID-19 with Asthma?
- Drugs: Buying Prescription Drugs Online Safely
- How To Reduce Your Medication Costs
- Pharmacy Visit, How To Get The Most Out of Your Visit
- Indications for Drugs: Approved vs. Non-approved
- Drugs: The Most Common Medication Errors
- Medication Disposal
- Dangers of Mixing Medications
- Generic Drugs, Are They as Good as Brand-Names?
Medications & Supplements
- ritonavir (Norvir)
- saquinavir (Invirase, Fortovase - discontinued)
- indinavir, Crixivan
- nelfinavir, Viracept
- Drugs: Questions to Ask Your Doctor or Pharmacist about Your Drugs
- Drug Interactions
- atazanavir (Reyataz)
- fosamprenavir - oral, Lexiva
- Protease Inhibitors (PI Drug Class)
- Side Effects of Norvir (ritonavir)
- Side Effects of Kaletra (lopinavir and ritonavir)
Prevention & Wellness
- Antiviral Trio Shows Mettle Against COVID-19
- Lots of Drugs Are Being Tested Against COVID-19 -- But Will Any Work?
- The Lowdown on COVID-19 Treatments
- Tocilizumab (Actemra) for COVID-19 Coronavirus Treatment
- 3 in 4 U.S. Hospitals Treating COVID-19 Patients: Report
- Anti-Parasite Drug Ivermectin Stunts COVID-19 Virus Culture in Lab Study
- Another COVID-19 Vaccine Being Tested in Mice
- Amid COVID-19 Crisis, Blood Donor Restrictions Eased for Gays
- Asthma, COPD Raise Odds for Severe COVID-19, Lung Experts Warn
- Abortion Bans Amid COVID-19
- As Unemployment and COVID-19 Cases Rise, Who Will Pay for Care?
- AI Might Spot Which COVID-19 Patients Are at Risk of Severe Disease
- Aralen, Plaquenil Shortages From COVID-19 Threaten Lupus, RA Patients
- Antiviral Drug Combo Ineffective Against Coronavirus
- Another Study Finds COVID-19 Typically Mild for Kids
- 3 More Coronavirus Deaths Reported at Washington State Nursing Home
- HIV Drug Combo May Help Prevent Malaria Reinfection
- Mom's HIV Drugs May Pass to Baby in Womb, Breast-Feeding
- Health Highlights: April 27, 2012
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
COVID-19 section data provided by Dominic Chan, Pharm. D. and infectious disease specialist at Legacy Health System